Company profile
Ultragenyx Pharmaceutical Inc. Insider Trading
RAREEvery SEC Form 4 insider trading filing for Ultragenyx Pharmaceutical Inc. (RARE) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001515673
- Filings
- 120
- Insiders
- 16
- Last filing
- 2026-09-15
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $2K across 1 transaction.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Ultragenyx Pharmaceutical Inc. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $6.9M.
90 day insight
Over the last 90 days, Ultragenyx Pharmaceutical Inc. insiders sold $2K across 1 transaction with no open-market purchases.
- Most active insider: Howard Horn with 2 transactions totaling $273K.
- Largest single sale: $156K by Howard Horn on Jul 1, 2026.
- 80% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Theodore Alan Huizenga | RARE | Sale10b5 | 1,283 | $13.57 | $17K |
| Sep 3, 2026 | Theodore Alan Huizenga | RARE | Sale | 161 | $13.99 | $2K |
| Aug 3, 2026 | Howard Horn | RARE | Sale10b5 | 4,696 | $24.92 | $117K |
| Aug 3, 2026 | Karah Herdman Parschauer | RARE | Sale10b5 | 1,900 | $24.92 | $47K |
| Jul 1, 2026 | Howard Horn | RARE | Sale10b5 | 4,698 | $33.13 | $156K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=RARE" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Ultragenyx Pharmaceutical Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →